WILEX Inc. and GeneDiagnostics Inc. Partner to Commercialize Serum HER-2/neu Test in China

News   Jan 23, 2013

 
WILEX Inc. and GeneDiagnostics Inc. Partner to Commercialize  Serum HER-2/neu Test in China
 
 
 
 

RELATED ARTICLES

Potential Barcode Identified for a Form of Alcoholic Liver Disease

News

NIAAA-supported researchers have discovered that extracellular vesicles released by liver cells in a mouse model of alcoholic steatohepatitis contain a miRNA signature detectable in the blood.

READ MORE

Optofluidic Device Detects Tumour Cells in Blood

News

A team of researchers has patented a mobile device that can monitor cancer quickly, cheaply, effectively and non-invasively.

READ MORE

Inflammatory Biomarkers Indicating Brain Injury Identified

News

Researchers at the University of Birmingham have identified inflammatory biomarkers which indicate whether the brain has suffered injury. It is hoped that the biomarkers could be used to develop a diagnostic test to rapidly detect brain injury at the scene of an incident.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE